Why Wall Street Loves to Hate Mylan's CEO

摘要

Heather Bresch elevated generic-drug maker Mylan from dinky to dominant - and more than doubled its stock price. But to some angry investors, she's still "what's her face." AT 6 A.M. ON THURSDAY, July 23, Heather Bresch was running on the treadmill in her home gym when she found out that four men in Amsterdam had effectively seized control of half her company.